Topic: ADHD

Head with brain in cupped hand

Alcobra abandons troubled lead drug

Alcobra took a body blow last year when the FDA placed a clinical hold on its lead drug metadoxine, but a failed phase 3 trial has now delivered a coup de grâce for the program.